Min-Horn Tsai

Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial

C. Shun, Chieh-Chang Chen, Chi-Yang Chang, 2020, Therapeutic advances in gastroenterology.

Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan

Ming-Shiang Wu, Chieh-Chang Chen, Wen-Hao Hu, 2020, Journal of gastroenterology and hepatology.

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.

E. El-Omar, C. Shun, Jaw-Town Lin, 2022, The lancet. Gastroenterology & hepatology.

Cytomegalovirus enteritis in immunocompetent patients: Report of two cases diagnosed using single‐balloon enteroscopy

Hsiu‐Po Wang, C. Tu, C. Liang, 2016 .

Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis

Jaw-Town Lin, Yi-Chia Lee, Ming-Shiang Wu, 2022, Helicobacter.

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial

Wen-Lun Wang, C. Shun, Jaw-Town Lin, 2018, The Journal of antimicrobial chemotherapy.

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.

E. El-Omar, C. Shun, Jaw-Town Lin, 2023, The lancet. Gastroenterology & hepatology.